15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Immatics NV, 5 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $18.00 to $25.00, so the covering firms are broadly aligned. The average target of $21.25 sits 143% above the current $8.74. The rating mix has stayed broadly stable, with Buy-side ratings easing from 6 to 5 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.50 next quarter toward $-1.90 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Strong Buy
Strong Buy00%
Buy5100%
Hold00%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to Immatics NV.
As of Jul, 5 of 5 firms rate IMTX a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
IMTX EPS & revenue forecast
EPS · NEXT QUARTER
$-0.50
Range $-0.59 – $-0.36 · 8 analysts · +2% YoY
Next period, 8 analysts expect Immatics NV to earn $-0.50 a share (range $-0.59 – $-0.36), versus $-0.49 a year earlier. Full-year consensus is $-1.94, growing to $-1.90 the year after.
REVENUE · NEXT QUARTER
$11.7M
Range $3.9M – $16.5M · 8 analysts · +94% YoY
Revenue is expected to reach $11.7M (range $3.9M – $16.5M), +93.8% year-over-year. Full-year consensus is $46.9M, rising to $48.9M next year.
Top analysts covering Immatics NV
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on IMTX.
#1
Geulah Livshits
Chardan Capital · Rank #100
Buy
$25.00+186.0% to target
Overall win rate
44%
+ Follow
#2
Joseph Catanzaro
Piper Sandler · Rank #219
Buy
$19.00+117.4% to target
Overall win rate
41%
+ Follow
#3
PJ
Paul Jeng
Guggenheim
Buy
$19.00+117.4% to target
Coverage
—
+ Follow
#4
JS
James Shin
Deutsche Bank
Buy
$10.00+14.4% to target
Coverage
—
+ Follow
#5
ES
Eric Schmidt
Cantor Fitzgerald
Buy
No targeton IMTX
Coverage
—
+ Follow
IMTX stock forecast FAQ
What is IMTX's average 12-month price target?+
The 4 analysts with a live target average $21.25 for Immatics NV over the next 12 months, ranging from a $25.00 high to a $18.00 low.
Is IMTX stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 5 analyst ratings, 5 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for IMTX?+
The Street-high target is $25.00 (Chardan Capital), and the Street-low is $18.00 (Jefferies). The average of all 4 active targets is $21.25.
How many Wall Street analysts cover IMTX?+
5 analysts have an active rating on Immatics NV, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering IMTX?+
Among analysts who currently cover IMTX, Geulah Livshits of Chardan Capital has the strongest overall Quantellect track record (Rank #100). Their current call is Buy with a $25.00 target.
What is Immatics NV's projected EPS for next quarter?+
The consensus estimate is $-0.50 per share (range $-0.59 – $-0.36) across 8 analysts. Full-year EPS is projected at $-1.94, rising to $-1.90 the following year.
How much revenue is Immatics NV expected to report next quarter?+
Consensus revenue is $11.7M (range $3.9M – $16.5M). Full-year revenue is projected at $46.9M, growing to $48.9M next year.
Have analysts been upgrading or downgrading IMTX lately?+
As of Jul, 5 of 5 firms rate IMTX a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their IMTX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
